Longitudinal Assessment of OCT-Based Measures of Foveal Cone Structure in Achromatopsia
Investigative Ophthalmology & Visual Science2024Vol. 65(4), pp. 16–16
Citations Over Time
Garrett Grissim, Ashleigh Walesa, Hannah M. Follett, Brian P. Higgins, Kaitlin Goetschel, Heather Heitkotter, Joseph Carroll
Abstract
ACHM appears to be a generally stable condition, at least over the follow-up period assessed here. As cones are the cellular targets for emerging gene therapies, stable EZ and ONL thickness demonstrate therapeutic potential for ACHM, although other aspects of the visual system need to be considered when determining the best timing for therapeutic intervention.
Related Papers
- → High-Resolution In Vivo Imaging in Achromatopsia(2011)126 cited
- → Residual Foveal Cone Structure in CNGB3-Associated Achromatopsia(2016)109 cited
- Interocular symmetry of foveal cone topography in achromatopsia (ACHM)(2018)
- Impact of segmentation density on spectral domain optical coherence tomography (SD-OCT) assessments in Stargardt disease.(2016)
- → Isolated foveal hypoplasia – A case report(2023)